Gratus Capital LLC Novo Nordisk A S Transaction History

Gratus Capital LLC

$2.39 Billion
Q2 2024

A detailed history of Gratus Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gratus Capital LLC holds 44,186 shares of NVO stock, worth $3.95 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

44,186

Previous 31,668 39.53%

Holding current value

$3.95 Million

Previous $4.07 Million 55.12%

% of portfolio

0.26%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$122.71 - $146.91 $1.54 Million - $1.84 Million	12,518 Added 39.53%	44,186 $6.31 Million
Q4 2023 Feb 07, 2024	SELL	$87.78 - $105.45 $13,167 - $15,817	-150 Reduced 0.47%	31,668 $3.28 Million
Q3 2023 Oct 26, 2023	BUY	$90.94 - $199.54 $1.45 Million - $3.17 Million	15,909 Added 100.0%	31,818 $2.89 Million
Q1 2023 Apr 19, 2023	SELL	$132.34 - $159.14 $157,219 - $189,058	-1,188 Reduced 6.95%	15,909 $2.53 Million
Q3 2022 Nov 03, 2022	SELL	$95.28 - $116.93 $37,063 - $45,485	-389 Reduced 2.22%	17,097 $1.7 Million
Q2 2022 Jul 29, 2022	SELL	$103.24 - $121.81 $23,229 - $27,407	-225 Reduced 1.27%	17,486 $1.95 Million
Q1 2022 Apr 29, 2022	SELL	$93.1 - $112.54 $73,362 - $88,681	-788 Reduced 4.26%	17,711 $1.97 Million
Q4 2021 Jan 31, 2022	BUY	$95.88 - $117.08 $31,448 - $38,402	328 Added 1.81%	18,499 $2.07 Million
Q3 2021 Nov 05, 2021	BUY	$84.42 - $106.62 $59,600 - $75,273	706 Added 4.04%	18,171 $1.75 Million
Q2 2021 Aug 10, 2021	SELL	$67.66 - $84.76 $547,707 - $686,132	-8,095 Reduced 31.67%	17,465 $1.46 Million
Q1 2021 May 04, 2021	SELL	$67.06 - $75.82 $109,777 - $124,117	-1,637 Reduced 6.02%	25,560 $1.72 Million
Q4 2020 Feb 03, 2021	BUY	$63.89 - $73.8 $3,641 - $4,206	57 Added 0.21%	27,197 $1.9 Million
Q3 2020 Oct 30, 2020	SELL	$63.69 - $70.22 $25,794 - $28,439	-405 Reduced 1.47%	27,140 $1.88 Million
Q2 2020 Aug 11, 2020	SELL	$58.54 - $67.94 $36,938 - $42,870	-631 Reduced 2.24%	27,545 $1.8 Million
Q1 2020 May 01, 2020	SELL	$49.46 - $64.78 $28,142 - $36,859	-569 Reduced 1.98%	28,176 $1.7 Million
Q4 2019 Feb 07, 2020	SELL	$49.86 - $58.26 $56,092 - $65,542	-1,125 Reduced 3.77%	28,745 $1.66 Million
Q3 2019 Oct 30, 2019	SELL	$47.54 - $53.43 $16,639 - $18,700	-350 Reduced 1.16%	29,870 $1.54 Million
Q2 2019 Aug 07, 2019	BUY	$46.79 - $52.47 $27,138 - $30,432	580 Added 1.96%	30,220 $1.54 Million
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $4,172 - $4,736	90 Added 0.3%	29,640 $1.55 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $4,154 - $4,725	100 Added 0.34%	29,550 $1.36 Million
Q3 2018 Nov 09, 2018	SELL	$46.76 - $51.24 $18,704 - $20,496	-400 Reduced 1.34%	29,450 $1.39 Million
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $50,933 - $57,983	-1,150 Reduced 3.71%	29,850 $1.38 Million
Q2 2017 Aug 08, 2017	BUY	N/A	31,000	31,000 $1.33 Million

Others Institutions Holding NVO

# of Institutions

1,884

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $202B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.

Account

Gratus Capital LLC Novo Nordisk A S Transaction History